Latest Production Development News

Enlitic, Inc. has launched a two-tranche institutional placement to raise A$10 million, underpinning its strategic collaboration with GE HealthCare and fueling expansion in AI-enabled medical imaging data migration.

Enlitic has formalised a binding MOU with GE HealthCare to deliver multi-million-dollar migration services, contingent on raising A$10 million through a new capital placement. This partnership and funding round mark a pivotal step in Enlitic’s growth strategy within AI-driven medical imaging.

Codeifai Limited has raised $250,000 through unsecured convertible loans, positioning the company to accelerate platform development and marketing ahead of its upcoming AGM.

WiseTech Global has confirmed its participation in the strategic review process initiated by US-based e2open, amid media speculation of a potential acquisition. While discussions remain preliminary with no certainty of a deal, the move aligns with WiseTech’s ongoing acquisition-driven growth strategy.

BluGlass Limited has launched a $6 million Share Purchase Plan (SPP) offering new shares with attaching options to eligible shareholders, aiming to fund the scale-up of its visible laser production and support ongoing product development.

HITIQ Ltd has successfully completed a $680,000 placement and launched a $2.92 million rights issue, positioning the company to fund its strategic shift towards the consumer market and expand its footprint in the US.

Anagenics Limited reported a cash outflow of $424K for Q3 2025 but maintains robust liquidity with $1.48 million in available funding, supported by a mix of secured and unsecured loans.

BlinkLab Limited has raised A$7.66 million through a well-supported placement to accelerate FDA regulatory trials for its autism and ADHD diagnostic platforms, leveraging its innovative smartphone-based technology.

Anatara Lifesciences has obtained a $400,000 loan advance from a major shareholder group against its estimated R&D tax refund for the first half of FY2025, providing crucial funding to support ongoing clinical trials and product development without immediate capital raising.

8common Limited reported a record Q3 FY25 SaaS and transaction revenue of $1.1 million, alongside a 33% reduction in operational costs, supported by technology upgrades and a $1.5 million financing facility.

Nanoveu Limited has completed its strategic acquisition of EMASS, advancing its foothold in ultra-low-power AI-driven edge computing. The company also strengthened its leadership team and secured additional capital to fuel growth.

OpenLearning Limited reported a 12% year-on-year increase in SaaS annual recurring revenue to $2.364 million in Q1 FY25, driven by AI-powered product adoption and international customer growth. Strategic acquisitions and partnerships are positioning the company for larger contracts and diversified revenue streams.